Come up with a name for your new list and we'll add to it:
AlphaCore Pharma was acquired by
MedImmune on April 04, 2013.
AlphaCore Pharma is developing ACP-501 (rhLCAT) for the treatment of the orphan disease familial LCAT deficiency (FLD) and for the acute treatment of atherosclerosis. In April 2013, AlphaCore Pharma …